“Venlafaxine Extended Release Acceptable and Tolerable for Major Depressive Disorder: A Study”

https://pubmed.ncbi.nlm.nih.gov/38117259

The study found that venlafaxine extended release at a dose of 300 mg/day was acceptable, tolerable, and showed good adherence in patients with major depressive disorder.